Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance: Part I - Zhou, Shu-Feng (Clinical pharmacokinetics, 2009)
Keywords: Adrenergic beta-Antagonists - metabolism; Alleles; Angina Pectoris - drug therapy; Animals; Anopheles; Anti-Arrhythmia Agents - metabolism; Antidepressants, Tricyclic; Biological and medical sciences; Biotransformation - genetics; Chromosomes, Human, Pair 22 - genetics; Cytochrome P-450; Cytochrome P-450 CYP2D6 - genetics; Cytochrome P-450 CYP2D6 - metabolism; Female; Flecainide; Gastrointestinal agents; General pharmacology; Genetic aspects; Haloperidol; Humans; Internal Medicine; Male; Medical sciences; Medicine; Medicine & Public Health; Metabolites; Morphine; Pharmacogenetics; Pharmacokinetics. Pharmacogenetics. Drug-receptor interactions; Pharmacology. Drug treatments; Pharmacology/Toxicology; Pharmacotherapy; Polymorphism, Genetic; Propranolol hydrochloride; Review Article; Substrate Specificity - genetics; Flecainide; Propafenone; Mexiletine; Carvedilol; Timolol; Human; Genotype; Genetic variability; Enzyme; Cytochrome P450; Polymorphism